Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-14
SponsorUniversity of Baghdad
About this trial
This study will be conducted to evaluate the effectiveness of a clear expander fabricated from 2-mm biocompatible polyethylene terephthalate glycol (PETG) thermoforming material integrated with an expansion screw in achieving dental and skeletal expansion in adolescent patients, compared with the conventional Hyrax expander.
Eligibility criteria
Qualifiers
Patients' age at the start of treatment will range from 10-14 years.
Unstable unilateral or bilateral posterior crossbite due to maxillary constriction.
The first molars are fully erupted.
Good oral health free from caries and periodontal problems at the start of treatment.
Disqualifiers
Patients with obvious facial asymmetry.
Patients with orofacial cleft.
Patients with previous orthodontic treatment.
Patients with bad oral habits.
Trial design
Treatments tested in this trial
- New clear expander
- Hyrax expander
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov